Enhanced uptake of ifosfamide into GH3 prolactinomas with hypercapnic hyperoxic gases monitored in vivo by 31P MRS

Neoplasia

Volumn 4, Issue 6, 2002, Pages 539-543

  Rodrigues, Loreta M ^a   Robinson, Simon P ^a   McSheehy, Paul M J ^b   Stubbs, Marion ^a   Griffiths, John R ^a  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^b NOVARTIS PHARMA AG   (Switzerland)

Author keywords

31P MRS; Hypercapnia; Hyperoxia; Ifosfamide; Pharmacokinetics

Indexed keywords

CARBOGEN; CARBON DIOXIDE; IFOSFAMIDE; PHOSPHORUS 31; ALKYLATING AGENT; OXYGEN; PHOSPHORUS;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREATHING; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOTOXICITY; DRUG EFFICACY; DRUG POTENTIATION; DRUG UPTAKE; DYSPNEA; FEMALE; GAS ANALYSIS; HYPERCAPNIA; HYPEROXIA; IN VIVO STUDY; NONHUMAN; PRIORITY JOURNAL; PROLACTINOMA; RAT; VASODILATATION; ANIMAL; HYPOPHYSIS TUMOR; METABOLISM; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; TISSUE DISTRIBUTION; WISTAR RAT;

ANIMALS; ANTINEOPLASTIC AGENTS, ALKYLATING; CARBON DIOXIDE; FEMALE; HYPERCAPNIA; HYPEROXIA; IFOSFAMIDE; MAGNETIC RESONANCE SPECTROSCOPY; OXYGEN; PHOSPHORUS; PHOSPHORUS ISOTOPES; PITUITARY NEOPLASMS; PROLACTINOMA; RATS; RATS, WISTAR; TISSUE DISTRIBUTION;

EID: 0036859529     PISSN: 15228002     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.neo.7900259     Document Type: Article

References (22)

1. Jain RK (1991). Therapeutic implications of tumor physiology. Curr Opin Oncol 3, 1105-108.
2. Song CW (1998). Modification of Blood Flow. In Blood Perfusion and Microenvironment of Human Tumours. M Molls, and P Vaupel (Eds). Springer-Verlag, Berlin. pp. 193-207.
3. Robinson SP, Howe FA, and Griffiths JR (1995). Non-invasive monitoring of carbogen-induced changes in tumour blood flow and oxygenation by functional magnetic resonance imaging. Int J Radiat Oncol Biol Phys 32, 855-59.
4. Thews O, Kelleher DK, and Vaupel P (2002). Dynamics of tumour oxygenation and red blood cell flux in response to inspiratory hyperoxia combined with different levels of inspiratory hypercapnia. Radiother Oncol 62, 77-85.
5. Howe FA, Robinson SP, Rodrigues LM, and Griffiths JR (1999). Flow and oxygen dependent (FLOOD) contrast MR imaging to monitor the response of rat tumours to carbogen breathing. Magn Reson Imaging 17, 1307-18.
6. Rojas A (1991). Radiosensitisation with normobaric oxygen and carbogen. Radiother Oncol 20(Suppl), 65-70.
7. 31P MRS in rat tumours; increased uptake and cytotoxicity induced by carbogen breathing in GH3 prolactinomas. Br J Cancer 76(1), 62-68.
8. McSheehy PMJ, Robinson SP, Ojugo ASE, Aboagye EO, Canell MBV, Leach MO, Judson IR, and Griffiths JR (1998). Carbogen breathing increases 5-fluorouracil uptake and cytotoxicity in hypoxic murine RIF-1 tumours: A magnetic resonance study in vivo. Cancer Res 58, 1185-94.
9. Bean J (1945). Effects of oxygen at increased pressure. Physiol Rev 25, 16-18.
10. Griffiths JR, Taylor NJ, Howe FA, Saunders MI, Robinson SP, Hoskin PJ, Powell MEB, Thoumine M, Caine LA, and Baddeley H (1997). The response of human tumours to carbogen breathing, monitored by gradient-recalled echo magnetic resonance imaging. Int J Radiat Oncol Biol Phys 39, 697-701.
11. Taylor NJ, Baddeley H, Goodchild KA, Powell MEB, Thoumine M, Culver LA, Stirling JJ, Saunders MI, Hoskin PJ, Phillips H, Padhani AR, and Griffiths JR (2001). BOLD MRI of human tumour oxygenation during carbogen breathing. J Magn Reson Imaging 14, 156-63.
12. Stubbs M, Robinson SP, Rodrigues LM, Parkins CS, Collingridge DR, and Griffiths JR (1998). The effects of host carbogen (95% oxygen/5% carbon dioxide) breathing on metabolic characteristics of Morris hepatoma 9618a. Br J Cancer 78(11), 1449-56.
13. 19F NMR. Br J Cancer 50, 113-17.
14. Kamm YJL, Heerschap A, and Wagener DJT (2000). Effects of carbogen breathing on the pharmacodynamics of 5-fluorouracil in a murine colon carcinoma. Eur J Cancer 36, 1180-86.
15. Griffiths JR, McIntyre D, Howe FA, McSheehy PMJ, Ojugo ASE, Rodrigues LM, Wadsworth P, Price NM, Lofts F, Nicholson G, Smid K, Noordhuis P, Peters GJ, and Stubbs M (2001). Issues of normal tissue toxicity in patient and animal studies; effect of carbogen breathing in rats after 5-fluorouracil treatment. Acta Oncol 40(5), 609-14.
16. Powell MEB, Collingridge DR, Saunders MI, Hoskin PJ, Hill SA, and Chaplin DJ (1999). Improvement in human tumour oxygenation with carbogen of varying carbon dioxide concentrations. Radiother Oncol 50, 167-71.
17. 2, microcirculatory function and radiosensitivity. Int J Radiat Oncol Biol Phys 40, 943-51.
18. 2* and arterial blood gases. Magn Reson Imaging 19, 161-66.
19. Benedict FG (1934). Die oberflachen bestimmung verschiedener tiergattungen. Ergeb Physiol 36, 300-46.
20. Prysor-Jones RA, and Jenkins JS (1981). Effect of bromocriptine on DNA synthesis, growth and hormone secretion of spontaneous pituitary tumours in rat. J Endocrinol 88, 463-69.
21. 31P NMR signals using the variable projection method and prior knowledge. Magn Reson Med 6, 92-98.
22. 31P probes. NMR Biomed 12, 495-504.